Vancouver, British Columbia – June 26, 2025 – TheNewswire - Orion Nutraceuticals Inc., (CSE: ORI) (the “Company” or “Orion”) announces that it intends to seek shareholder approval to voluntarily delist its common shares from the Canadian Securities Exchange (the "CSE") at its annual general and special meeting of shareholders scheduled for July 4, 2025 (the “AGSM”).

 

The Company has determined that a voluntary delisting from the CSE (the "Delisting") is in the best interests of both shareholders and the Company. This decision has been made in light of prolonged weak market conditions and forms part of the Company’s broader strategy to preserve its business and working capital position.

 

The Company’s board of directors the (“Board”) has carefully considered all available options to maintain and sustain the Company’s operations. As part of this review, the Board identified the ongoing cost burden of remaining a listed issuer as a significant factor. After evaluating the cost-benefit implications, the Board concluded that proceeding with the Delisting represents a prudent course of action aimed at supporting the long-term interests of the Company and its shareholders.

 

Despite the Delisting, the Company will continue to be subject to ongoing disclosure and other obligations as a reporting issuer under applicable securities legislation in Canada. The Company is required to obtain the approval of its disinterested shareholders to approve the Delisting of its common shares from the CSE. In seeking such disinterested shareholder approval, the Company shall exclude all votes attached to the common shares held by the directors, officers and insiders of the Company, who collectively hold nil common shares.

 

For further details regarding the AGSM, please refer to the Company’s management information circular, available under its profile at www.sedarplus.ca.

 

About Orion Nutraceuticals Inc.

Orion Nutraceuticals Inc. is actively evaluating potential investment and acquisition opportunities. Orion shares trade in Canada on the CSE under the symbol ORI.

ON BEHALF OF THE BOARD

Guy Bourgeois, Director
Tel: (604) 687-2038

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this news release.

 

Forward-Looking Statements

This news release contains "forward-looking information" and "forward-looking statements" (collectively, “forward-looking statements”) within the meaning of applicable securities laws, including statements regarding the Company’s intention to delist from CSE, the anticipated benefits of the Delisting, the Company’s ongoing obligations as a reporting issuer, and the potential impact on shareholders and trading liquidity. Forward-looking statements are based on the opinions, assumptions and estimates of management as of the date they are made and are subject to various known and unknown risks and uncertainties.

These risks include, but are not limited to, changes in market conditions, regulatory developments, the Company’s ability to maintain compliance with applicable laws, and other factors that may cause actual outcomes to differ materially from those expressed or implied by such forward-looking statements.

Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by applicable law, the Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.